Tappenden, Paul http://orcid.org/0000-0001-6612-2332
Carroll, Christopher
Stevens, John
Simpson, Emma
Thokala, Praveen
Wong, Ruth
Wright, Josh
Auer, Rebecca
Funding for this research was provided by:
Health Technology Assessment Programme (14/25)
Article History
First Online: 27 June 2018
Compliance with Ethical Standards
:
: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (Project No. 15/148/03) [see the HTA programme website for further project information;ExternalRef removed]. This summary of the ERG report was compiled after NICE issued the FAD. All authors have commented on the submitted manuscript and have given their approval for the final version to be published. The views expressed in this report are those of the authors and not necessarily those of the NIHR HTA Programme. Any errors are the responsibility of the authors.
: Rebecca Auer acted as an advisor for Janssen for their submission to NICE and was paid a small advisory fee for this role. Since the completion of this appraisal, she has received a grant for a clinical trial that is anticipated to begin in November 2018. Paul Tappenden, Christopher Carroll, John Stevens, Emma Simpson, Praveen Thokala, Ruth Wong and Josh Wright declare no conflicts of interest.